Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Social network for doctors SERMO launches Spanish version

Marksthe first non-English capability for the US company

Online doctor physician HCP communities 

The expansion of US-based social network for doctors SERMO this year continues apace with the debut on its first non-English capabilities.

After opening doors in Europe and Canada earlier this year the company has added translation functionality to its website and mobile app to allow Mexican and Spanish doctors to more easily engage in conversations on the network.

This will potentially give it access to 260,000 Mexican and 232,000 Spanish doctors, building on its status as the largest global social network exclusively for physicians.

Peter Kirk, CEO of SERMO, said: “Before SERMO, doctors did not have a virtual channel to collaborate with peers across borders. 

“With differing medical practices around the globe and lots of remote areas where there are a low number of specialists, the ability to exchange medical wisdom with speed and security in a doctors-only social network is highly valuable and potentially life-saving for patients.”

The company is in the midst of global expansion plans and said that,  already having longstanding teams in Puebla, Mexico, and Barcelona, Spain, it was natural to make Spanish its first foreign language.

6th October 2015

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

3 reasons why clinical trials will thrive in 2021
It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...

Infographics